ECONOMIC OUTCOMES AND REAL-WORLD ADHERENCE OF PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES TREATED WITH L-GLUTAMINE, VOXELOTOR, AND CRIZANLIZUMAB IN THE UNITED STATES

被引：0
|
作者：
Udeze, C. [1 ]
Jerry, M. [2 ]
Evans, K. [2 ]
Li, N. [1 ]
Jain, S. [1 ]
Andemariam, B. [3 ]
机构：
[1] Vertex Pharmaceut Inc, Boston, MA USA
[2] Merative, Ann Arbor, MI USA
[3] Univ Connecticut Hlth, Farmington, CT USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE132
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [21] HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN CANADA
    Lilly, L.
    Udeze, C.
    Nightingale, N.
    Wang, I
    Murray, J.
    Penaranda, C.
    Neish, C.
    Li, N.
    Kuo, K.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S125 - S125
  • [22] HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN ITALY
    Udeze, C.
    Dovizio, M.
    Veronesi, C.
    Esposti, Degli L.
    Li, N.
    Dang, T. X. M. P.
    Forni, G. L.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S133 - S133
  • [23] Healthcare resource utilization among patients with Sickle Cell Disease with recurrent vaso-occlusive crises in Germany
    Tuzin, P.
    Udeze, C.
    Kunzweiler, C.
    Li, N.
    Baldwin, J.
    Barth, S. D.
    Vetter, C.
    Dombrowski, S.
    Georgiadou-Schmidt, E.
    Meisel, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 298 - 298
  • [24] MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN FRANCE
    Baldwin, J.
    Udeze, C.
    Li, N.
    Boulmerka, L.
    Dahal, L.
    Pesce, G.
    Quignot, N.
    Jiang, H.
    Galacteros, F.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S47 - S47
  • [25] HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN FRANCE
    Baldwin, J.
    Udeze, C.
    Li, N.
    Boulmerka, L.
    Dahal, L.
    Pesce, G.
    Quignot, N.
    Jiang, H.
    Galacteros, F.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S192 - S192
  • [26] HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN GERMANY
    Kunzweiler, C.
    Udeze, C.
    Li, N.
    Baldwin, J.
    Tuzin, P.
    Barth, S. D.
    Vetter, C.
    Dombrowski, S.
    Georgiadou-Schmidt, E.
    Meisel, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S91 - S92
  • [27] Intravenous Hydration and Associated Outcomes in Patients With Sickle Cell Disease Admitted With Vaso-Occlusive Crises: A Systematic Review
    Pandey, Sagar
    Tan, Ernestine Faye S.
    Bellamkonda, Amulya
    Aryal, Binit
    Karki, Sailesh
    Boddu, Gouthami
    Sapkota, Ranjit
    Changela, Madhav
    Kalavar, Madhumati
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [28] Real-World Outcomes and Digitally Monitored Quality of Life in Voxelotor-Treated Patients with Sickle Cell Disease
    Summers, Kim
    Agrippa, Orlando
    Shastri, Oliver
    Sharif, Seraj
    Anie, Kofi
    Telfer, Paul
    Lugthart, Sanne
    [J]. BLOOD, 2023, 142
  • [29] Relationship between Vaso-Occlusive Crisis and Quality of Life: An Analysis of Patients with Sickle Cell Disease in the United States
    Thom, Howard Z.
    Shafrin, Jason
    Keeney, Edna
    Zhao, Lauren M.
    Joseph, George J.
    Bhor, Menaka
    Rizio, Avery A.
    Bronte-Hall, Lanetta
    Shah, Nirmish
    [J]. BLOOD, 2019, 134
  • [30] ECONOMIC EVALUATION OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) GENE-EDITED THERAPY IN PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES
    Udeze, C.
    Xie, Y.
    Ogunsile, F. J.
    Mujumdar, U.
    Yang, H.
    Chen, X.
    Jeyakumar, S.
    Li, N.
    Wang, J.
    Lopez, A.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S91 - S91
12345